Catalyst Wire Dossier Catalyst Wire Dossier

DTG/TAF/FTC

dolutegravir/tenofovir alafenamide/emtricitabine
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DTG/TAF/FTC, covering 2023-02-08 to 2025-04-02. Get the full timeline:

Most recent: Clinical Trial Update: A Randomised, Phase 3 Non-inferiority Study of DOR/3TC/TDF Compared to DTG/TAF/FTC in Participants Infected With HIV-1 Starting First-line Antiretroviral Therapy [Phase 3]

See pricing